The AHA is hosting calls for all hospital and health system leaders to provide the latest information on and answer questions about the COVID-19 pandemic. The next call is July 9 from 2:30-3:45 p.m. ET. Food and Drug Administration Commissioner Stephen Hahn, M.D., will address FDA’s response to the COVID-19 epidemic, including emergency use authorizations, remdesivir distribution and vaccine clinical trials. 

In addition, AHA Board Chair Melinda Estes, M.D., AHA President and CEO Rick Pollack and AHA senior leaders will give updates on advocacy, regulatory and policy developments, as well as the association’s efforts to support members in their efforts to combat COVID-19. 

Callers are encouraged to dial in at least 10-15 minutes in advance. Please dial 800-469-8538 and enter the participant passcode 43576#.

Related News Articles

Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…